Your browser doesn't support javascript.
loading
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome.
Montal, Victor; Barroeta, Isabel; Bejanin, Alexandre; Pegueroles, Jordi; Carmona-Iragui, María; Altuna, Miren; Benejam, Bessy; Videla, Laura; Fernández, Susana; Padilla, Concepcion; Aranha, Mateus Rozalem; Iulita, Maria Florencia; Vidal-Piñeiro, Didac; Alcolea, Daniel; Blesa, Rafael; Lleó, Alberto; Fortea, Juan.
Affiliation
  • Montal V; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Barroeta I; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Bejanin A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pegueroles J; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Carmona-Iragui M; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Altuna M; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Benejam B; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Videla L; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Fernández S; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Padilla C; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Aranha MR; Barcelona Down Medical Center. Fundació Catalana Síndrome de Down, Barcelona, Spain.
  • Iulita MF; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Vidal-Piñeiro D; Barcelona Down Medical Center. Fundació Catalana Síndrome de Down, Barcelona, Spain.
  • Alcolea D; Barcelona Down Medical Center. Fundació Catalana Síndrome de Down, Barcelona, Spain.
  • Blesa R; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Lleó A; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Fortea J; Barcelona Down Medical Center. Fundació Catalana Síndrome de Down, Barcelona, Spain.
Ann Neurol ; 90(3): 407-416, 2021 09.
Article in En | MEDLINE | ID: mdl-34309066
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome / Metabolomics / Alzheimer Disease Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 2021 Document type: Article Affiliation country: España Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome / Metabolomics / Alzheimer Disease Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 2021 Document type: Article Affiliation country: España Country of publication: Estados Unidos